UBS Group Cuts UiPath (NYSE:PATH) Price Target to $15.00

UiPath (NYSE:PATH) had its price objective reduced by UBS Group from $19.00 to $15.00 in a report published on Wednesday morning, MarketBeat reports. UBS Group currently has a neutral rating on the stock.

Other research analysts have also recently issued reports about the company. Truist Financial lifted their price objective on UiPath from $12.00 to $17.00 and gave the company a “hold” rating in a research report on Friday, September 4th. TD Cowen increased their target price on shares of UiPath from $13.00 to $16.00 and gave the stock a “hold” rating in a report on Friday, September 4th. Mizuho raised their target price on shares of UiPath from $12.00 to $14.00 and gave the stock a “neutral” rating in a research note on Friday, September 4th. Barclays lifted their price target on shares of UiPath from $14.00 to $17.00 and gave the company an “equal weight” rating in a report on Friday, September 4th. Finally, Royal Bank Of Canada dropped their price target on shares of UiPath from $17.00 to $15.00 and set a “sector perform” rating for the company in a research report on Wednesday. Four research analysts have rated the stock with a Buy rating, sixteen have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $16.06.

UiPath Stock Performance

Shares of UiPath stock opened at $12.47 on Wednesday. UiPath has a one year low of $9.20 and a one year high of $19.84. The stock’s fifty day moving average is $14.53 and its 200 day moving average is $12.23. The stock has a market cap of $6.50 billion, a P/E ratio of 18.62, a P/E/G ratio of 1.18 and a beta of 1.02.

UiPath (NYSE:PATH) last released its earnings results on Thursday, September 3rd. The company reported $0.15 earnings per share for the quarter, meeting the consensus estimate of $0.15. The company had revenue of $410.26 million for the quarter, compared to the consensus estimate of $397.77 million. UiPath had a return on equity of 9.70% and a net margin of 21.03%.UiPath’s quarterly revenue was up 13.3% compared to the same quarter last year. During the same period in the previous year, the business earned $0.15 earnings per share. Analysts predict that UiPath will post 0.49 EPS for the current year.

Insider Transactions at UiPath

In related news, COO Ashim Gupta sold 117,339 shares of the stock in a transaction dated Friday, September 11th. The stock was sold at an average price of $13.85, for a total transaction of $1,625,145.15. Following the completion of the sale, the chief operating officer owned 2,037,377 shares in the company, valued at approximately $28,217,671.45. This trade represents a 5.45% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Raghavendra Malpani sold 40,464 shares of UiPath stock in a transaction that occurred on Thursday, September 17th. The shares were sold at an average price of $14.00, for a total value of $566,496.00. Following the sale, the insider directly owned 1,582,213 shares in the company, valued at $22,150,982. This trade represents a 2.49% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 1,560,150 shares of company stock valued at $24,727,357 over the last 90 days. Company insiders own 22.44% of the company’s stock.

Institutional Investors Weigh In On UiPath

Several institutional investors and hedge funds have recently modified their holdings of PATH. Trifecta Capital Advisors LLC purchased a new position in shares of UiPath in the second quarter worth $27,000. AdvisorNet Financial Inc grew its stake in UiPath by 750.0% during the first quarter. AdvisorNet Financial Inc now owns 3,400 shares of the company’s stock valued at $38,000 after acquiring an additional 3,000 shares in the last quarter. REAP Financial Group LLC purchased a new position in UiPath during the fourth quarter valued at $44,000. Global Retirement Partners LLC bought a new stake in UiPath in the 2nd quarter valued at $57,000. Finally, EverSource Wealth Advisors LLC increased its holdings in UiPath by 36.5% in the 4th quarter. EverSource Wealth Advisors LLC now owns 4,968 shares of the company’s stock valued at $81,000 after acquiring an additional 1,329 shares during the last quarter. Institutional investors own 62.50% of the company’s stock.

UiPath News Roundup

Here are the key news stories impacting UiPath this week:

• Positive Sentiment: UiPath customer adoption is demonstrating real-world demand for agentic automation, with one customer reportedly processing approximately 100,000 medical billing cases per week. This supports the company’s case that its technology can deliver measurable productivity gains at enterprise scale. Accountable intelligence – how a UiPath customer is using agentic automation to process 100,000 medical billing cases a week
• Positive Sentiment: The company introduced Cartographer and additional workflow automation and software-testing capabilities intended to connect business processes, software agents and enterprise AI orchestration. These tools could expand UiPath’s addressable market if they accelerate customer adoption. UiPath’s new tool could unlock a much bigger wave of automated business processes
• Positive Sentiment: UiPath announced the 2026 GeekWire AI Breakthrough Award winners, showcasing enterprises using agentic AI in production. The recognition may improve market visibility and reinforce the company’s positioning in enterprise AI. UiPath Announces Winners of the 2026 Geekwire AI Breakthrough Awards
• Neutral Sentiment: Needham reaffirmed its Buy rating, while Barclays and TD Cowen maintained Hold ratings, indicating mixed Wall Street conviction rather than a clear consensus. Needham reaffirms Buy rating
• Negative Sentiment: BMO Capital Markets cut its price target from $18 to $15 and Canaccord Genuity reduced its target from $17 to $14; both firms now carry middle-ground ratings. UBS also lowered its target, adding to investor concerns about UiPath’s near-term upside. Why UiPath stock is down today
• Negative Sentiment: The stock’s decline was compounded by rising Treasury yields and a broader software-sector selloff. Although annual recurring revenue reached $1.938 billion, investors appeared focused on valuation pressure and the shares’ persistent monthly downtrend. UiPath stock falls as ARR reaches $1.938 billion

About UiPath

UiPath Inc (NYSE: PATH) develops enterprise automation software designed to help organizations automate repetitive, rules-based and increasingly complex business processes. Its platform combines robotic process automation (RPA), artificial intelligence, workflow orchestration and process intelligence to support automation across areas such as finance, customer service, human resources, information technology and operations.

The UiPath Platform includes tools for discovering and analyzing business processes, building and managing software robots, processing documents, testing applications and coordinating automated workflows.